JMJD2A participates in cytoskeletal remodeling to regulate castration-resistant prostate cancer docetaxel resistance

BACKGROUND: To investigate underlying mechanism of JMJD2A in regulating cytoskeleton remodeling in castration-resistant prostate cancer (CRPC) resistant to docetaxel. METHODS: Tissue samples from CRPC patients were collected, and the expression of JMJD2A, miR-34a and cytoskeleton remodeling-related...

Descripción completa

Detalles Bibliográficos
Autores principales: Cai, Xiang, Duan, Xi, Tang, Tielong, Cui, Shu, Wu, Tao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10170801/
https://www.ncbi.nlm.nih.gov/pubmed/37165308
http://dx.doi.org/10.1186/s12885-023-10915-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10170801/
https://www.ncbi.nlm.nih.gov/pubmed/37165308
http://dx.doi.org/10.1186/s12885-023-10915-1

Ejemplares similares